Clinical Trials on Lead Toxicity in Hong Kong

Total 150 results

The University of Hong Kong

Completed

Observation Study of the Pharmacokinetics of Adductor Canal Block

Toxicity, Drug

Hong Kong
The Hong Kong Polytechnic University
OPHTECS Corporation

Completed

Efficacy and Safety of cleadewGP for Rigid Contact Lenses

Contact Lens Solution Toxicity

Hong Kong
The University of Hong Kong

Unknown

The Impact of Indocyanine Green-enhanced Fluorescence Imaging on Bowel Transection in Left-sided Colorectal Resection

Anastomotic Leak

Hong Kong
The Hong Kong Polytechnic University

Not yet recruiting

Effects of tDCS for Enhancing Cognitive Function in Individuals With Persistent Post-Concussion Syndrome

Post-Concussion Syndrome | Functional Magnetic Resonance Imaging | Transcranial Direct Current Stimulation | Magnetic Resonance Spectroscopy

Hong Kong
The University of Hong Kong

Recruiting

Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning

Oral Squamous Cell Carcinoma

Hong Kong
The University of Hong Kong

Completed

HIFU Reapplication in Benign Nodules

Thyroid Nodule

Hong Kong
Chinese University of Hong Kong

Recruiting

The Microbiome of Oesophageal Squamous Cell Carcinoma

Esophageal Cancer | Microbial Colonization

Hong Kong
The University of Hong Kong

Completed

The Feasibility and Safety of the TOETVA for Benign Thyroid Nodules

Thyroid Diseases

Hong Kong
The University of Hong Kong

Completed

A Prospective Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Benign Thyroid Nodules

Benign Thyroid Nodules

Hong Kong
AstraZeneca

Completed

Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma

Head and Neck Cancer

Hong Kong, Singapore
Chinese University of Hong Kong

Not yet recruiting

Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients

Head and Neck Neoplasms | Oral Mucositis (Ulcerative) Due to Radiation | Chinese Medicine Oral Rinse

Hong Kong
The University of Hong Kong

Completed

Study on HRQOL and Cost-effectiveness Analysis in Management of Patients With <2cm Thyroid Nodules

Thyroid Nodules

Hong Kong
The University of Hong Kong

Suspended

A Trial Comparing USG-HIFU vs AS in Management of Low-risk PTMC

Papillary Thyroid Microcarcinoma

Hong Kong
Chinese University of Hong Kong

Recruiting

Application of 3D MR Neurogram for Intraparotid Facial Nerves Evaluation

Parotid Neoplasms

Hong Kong
The University of Hong Kong

Recruiting

Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Hong Kong
The University of Hong Kong

Unknown

Weekly Plasma EBV DNA for Non-metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Hong Kong
Chinese University of Hong Kong

Recruiting

Magnifying NBI for Occult NPC

Nasopharyngeal Carcinoma

Hong Kong
The University of Hong Kong

Unknown

Serial Plasma EBV DNA for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Hong Kong
The University of Hong Kong

Unknown

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

Hong Kong
Sanofi

Completed

Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

Hong Kong
Zeng Changhao

Recruiting

Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal Carcinoma

Dysphagia

Hong Kong
Chinese University of Hong Kong

Completed

MK-2206 in Recurrent Nasopharyngeal Carcinoma (MC1079)

Recurrent Nasopharyngeal Carcinoma

Hong Kong
Pamela Youde Nethersole Eastern Hospital

Completed

NBI to Detect Post-RT Mucosal Residual NPC

Nasopharyngeal Carcinoma

Hong Kong
Sanofi

Completed

Taxotere + Cisplatin in Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

Hong Kong
The University of Hong Kong
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt...

Completed

Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPC

Nasopharyngeal Carcinoma | Metastatic Cancer | Recurrent Carcinoma | Non-keratinizing Carinoma

Hong Kong
Chinese University of Hong Kong
Hong Kong Nasopharyngeal Cancer Study Group Limited

Completed

A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Nasopharyngeal Cancer

Hong Kong
Chinese University of Hong Kong

Completed

New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer

Advanced Nasopharyngeal Carcinoma

Hong Kong
Chinese University of Hong Kong

Active, not recruiting

Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis

Nasopharyngeal Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Nasopharyngeal Carcinoma (NPC) Axitinib

Recurrent or Metastatic NPC

Hong Kong
Chinese University of Hong Kong

Completed

Modified Vaccinia Ankara (MVA) Vaccine Study

Nasopharyngeal Neoplasms | Epstein-Barr Virus Infections

Hong Kong
Chinese University of Hong Kong

Completed

Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer - Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)

Esophageal Cancer

China
Chinese University of Hong Kong

Completed

Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy

Nasopharyngeal Cancer | Epstein-Barr Virus Infections

Hong Kong
CCTU

Active, not recruiting

NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer

NPC

Hong Kong, Singapore
Hospital Authority, Hong Kong
The Hong Kong Nasopharyngeal Cancer Study Group

Terminated

Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)

Carcinoma, Squamous Cell | Nasopharyngeal Neoplasms

China
Hospital Authority, Hong Kong
Hong Kong Nasopharyngeal Cancer Study Group Limited

Unknown

Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer

Nasopharyngeal Neoplasms

China
Hong Kong Nasopharyngeal Cancer Study Group Limited
Sanofi; The University of Hong Kong; Merck Sharp & Dohme LLC; Roche Pharma AG

Completed

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

Nasopharyngeal Carcinoma

China
Hospital Authority, Hong Kong
Hong Kong Nasopharyngeal Cancer Study Group Limited

Unknown

Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)

Carcinoma, Squamous Cell | Nasopharyngeal Neoplasms

China
Hong Kong Nasopharyngeal Cancer Study Group Limited
The Hong Kong Anti-Cancer Society; hong Kong Cancer Fund

Completed

Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Chinese University of Hong Kong

Completed

A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery

Urologic Neoplasms | Urologic Diseases | Nasopharyngeal Neoplasms | Colorectal Neoplasms | Oropharyngeal Neoplasms | Hypopharyngeal Neoplasms | Laryngeal Neoplasms | Oral Neoplasms | ENT Diseases

China
Johns Hopkins University
Janssen-Cilag Ltd.

Withdrawn

Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China, Singapore
Chinese University of Hong Kong
Queen Elizabeth Hospital, Hong Kong; Prince of Wales Hospital, Shatin, Hong...

Unknown

Dysphagia Rehabilitation for Nasopharyngeal Carcinoma Patients Post Radiotherapy

Nasopharyngeal Carcinoma | Radiotherapy

Hong Kong
Merck Sharp & Dohme LLC

Terminated

Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001)

Neoplasms | Head and Neck Neoplasms | Colorectal Neoplasms

Australia, Hong Kong
Shanghai Chest Hospital
Chang Gung Memorial Hospital; Tianjin Medical University Cancer Institute and... and other collaborators

Unknown

Pre-Surgery If Needed for Oesophageal Cancer (preSINO)

Esophageal Cancer

China, Hong Kong, Taiwan
Chinese University of Hong Kong

Completed

The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer (AP)

Squamous Cell Carcinoma of Esophagus

China
Hoffmann-La Roche

Completed

A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer

Nasopharyngeal Cancer

Hong Kong, Thailand, Indonesia, Taiwan, Malaysia
Cullinan Oncology, LLC
National Cancer Institute (NCI)

Terminated

Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC)

Nasopharyngeal Carcinoma | Nasopharyngeal Cancer

France, Singapore, United States, China, Hong Kong
Taiho Pharmaceutical Co., Ltd.

Terminated

Phase II Study of TAS-106 to Treat Head and Neck Cancer

Head and Neck Cancer

United States, Hong Kong, Singapore, Taiwan
National Cancer Institute (NCI)

Completed

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Recurrent Squamous Cell Carcinoma of the Nasopharynx | Stage IV Squamous Cell Carcinoma of the Nasopharynx

United States, Singapore, China
Sidney Kimmel Comprehensive Cancer Center at Johns...

Withdrawn

Head and Neck Cancer Treatment Related Dysphagia

Head and Neck Cancer | Dysphagia

United States, China, Australia, Canada
Alentis Therapeutics AG

Recruiting

Study of ALE.C04 in Patients With Head and Neck Cancer

Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma

United States, Hong Kong, Singapore, Spain, Canada, Italy

Clinical Trials on Lead Toxicity in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations